4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-007696
SVP, Chief Accounting Officer sold 1,562 shares at $9.45 ($14,766)
- SVP, Chief Accounting Officer acquired 20,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sabatini Brent SVP, Chief Accounting Officer | 2025-02-22 | Grant or award 10b5-1 | +20,000 | 48,189 | D | ||
| Sabatini Brent SVP, Chief Accounting Officer | 2025-02-24 | Sale 10b5-1 | −1,562 | $9.45 | $14,766 | 46,627 | D |
| Derivatives | |||||||
| Sabatini Brent SVP, Chief Accounting Officer | 2025-02-22 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +40,000 | 40,000 | D | ||
| Open-market sales · 1,562 sh · avg $9.45 · $14,766 | |||||||
Loading xslF345X05/wk-form4_1740515835.xml…